Advertisment
Indian Journal of Nephrology About us |  Subscription |  e-Alerts  | Feedback | Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Current Issue | Archives| Ahead of print | Search |Instructions |  Editorial Board  

Users Online:480

Official publication of the Indian Society of Nephrology
  Search
 
  
 ~  Similar in PUBMED
 ~  Search Pubmed for
 ~  Search in Google Scholar for
 ~  Article in PDF (332 KB)
 ~  Citation Manager
 ~  Access Statistics
 ~  Reader Comments
 ~  Email Alert *
 ~  Add to My List *
* Registration required (free)  

 
   References

 Article Access Statistics
    Viewed651    
    Printed15    
    Emailed0    
    PDF Downloaded47    
    Comments [Add]    

Recommend this journal

 


 
  Table of Contents  
LETTER TO THE EDITOR
Year : 2014  |  Volume : 24  |  Issue : 5  |  Page : 331-332
 

Authors' reply


Department of Nephrology, Seth G.S. Medical College and K.E.M. Hospital, Acharya Donde Marg, Parel, Mumbai, Maharashtra, India

Date of Web Publication11-Sep-2014

Correspondence Address:
V S Keskar
Department of Nephrology, Seth G.S. Medical College and K.E.M. Hospital, Acharya Donde Marg, Parel, Mumbai - 400 012,Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions



How to cite this article:
Keskar V S, Jamale T E, Hase N K. Authors' reply. Indian J Nephrol 2014;24:331-2

How to cite this URL:
Keskar V S, Jamale T E, Hase N K. Authors' reply. Indian J Nephrol [serial online] 2014 [cited 2020 May 31];24:331-2. Available from: http://www.indianjnephrol.org/text.asp?2014/24/5/331/140612


Sir,

We thank M. D. Al-Mendalawi. [1] for their interest in our case report [2] and the insightful comments. We agree that association of malaria and hemolytic uremic syndrome-thrombotic thrombocytopenia purpura (HUS-TTP) may not be causal and only a few cases have been described hitherto. However, ADAMTS13 activity and antigen levels have been reported to be reduced in patients with falciparum as well as vivax malaria. [3] This evidence of endothelial injury in malarial infections is intriguing and needs to be explored. Furthermore, given the vivax malaria increasingly being reported as a cause of severe malaria, [4] it will be interesting to study what proportion of them have HUS-TTP.

Thrombotic microangiopathy is a histologic description that is characteristic of several diverse disorders, such as malignant hypertension and scleroderma, as well as TTP and HUS. [5],[6] When the patients with microangiopathic hemolytic anemia and thrombocytopenia are initially evaluated, the comprehensive term TTP-HUS can probably be the best one to describe the clinical entity seen in our patient.

We agree that a complete evaluation including assessment of ADAMTS13 activity and genetic and autoimmune tests to identify a complement-related defect is required, which could not be done in our case. In absence of such a detailed evaluation, there remains a possibility of presence of underlying complement disorder where HUS was triggered by malarial infection. Infections, including diarrhea, are known as a trigger to develop HUS in patients having complement dysregulation. [7],[8]

 
  References Top

1.Al-Mendalawi MD. Hemolytic uremic syndrome associated with Plasmodium vivax malaria successfully treated with plasma exchange: Authors' reply. Indian J Nephrol 2014;24:331.   Back to cited text no. 1
  Medknow Journal  
2. Keskar V S, Jamale T E, Hase N K. Hemolytic uremic syndrome associated with Plasmodium vivax malaria successfully treated with plasma exchange. Indian J Nephrol 2014;24:35-7.   Back to cited text no. 2
[PUBMED]  Medknow Journal  
3. de Mast Q, Groot E, Asih PB, Syafruddin D, Oosting M, Sebastian S, et al. ADAMTS13 deficiency with elevated levels of ultra-large and active von Willebrand factor in P. falciparum and P. vivax malaria. Am J Trop Med Hyg 2009;80:492-8.   Back to cited text no. 3
    
4. Singh H, Parakh A, Basu S, Rath B. Plasmodium vivax malaria: Is it actually benign? J Infect Public Health 2011;4:91-5.   Back to cited text no. 4
    
5. Laszik ZG, Silva FG. Hemolytic-uremic syndrome, thrombotic thrombocytopenic purpura, and other thrombotic microangiopathies. In: Jennett JC, Olson JL, Schwartz MM, Silva FG, editors. Heptinstall's Pathology of the Kidney. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2007. p. 701-64.   Back to cited text no. 5
    
6. George JN. How I treat patients with thrombotic thrombocytopenic purpura: 2010. Blood 2010;116:4060-9.   Back to cited text no. 6
    
7. Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA, Macher MA, Niaudet P, Guest G, et al. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. J Am Soc Nephrol 2007;18:2392-400.   Back to cited text no. 7
    
8. Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 2010;5:1844-59.  Back to cited text no. 8
    




 

Top
Print this article  Email this article
 

    

Indian Journal of Nephrology
Published by Wolters Kluwer - Medknow
Online since 20th Sept '07